Allogene Therapeutics Inc (ALLO)

01:46 AM

Allogene Therapeutics (NASDAQ:ALLO) Shares Up 6.2%Here's What Happened - marketbeat.com

01:46 AM

09:33 AM

Allogeneic Cell Therapy Market Size to Hit USD 2.98 Bn by 2032, Driven by Off-the-Shelf Therapies - EIN News

09:33 AM

04:50 AM

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 earnings call transcript - MSN

04:50 AM

Apr 05, 2026

Pfizer in deal with Allogene to develop cancer cell therapies - AOL.com

Apr 05, 2026

Apr 04, 2026

Piper Sandler analysts bullish on Allogene Therapeutics (ALLO) ahead of key ALPHA3 data readout - MSN

Apr 04, 2026

Apr 03, 2026

ALLO SEC FilingsAllogene Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 03, 2026

Apr 02, 2026

Allogene Therapeutics SVP sells $13k in stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Allogene Therapeutics (ALLO) SVP sells shares in tax-related sell-to-cover - stocktitan.net

Apr 02, 2026

Apr 02, 2026

Chart Watch: What are the future prospects of Allogene Therapeutics Inc2026 Big Picture & Entry Point Strategy Guides - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

ALLO Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 01, 2026

Allogene Therapeutics Stock Gains Momentum from Sector Tailwinds () - aktiencheck.de

Apr 01, 2026

Apr 01, 2026

Allogene Therapeutics (NASDAQ: ALLO) notice to sell 2,867 shares - stocktitan.net

Apr 01, 2026

Mar 31, 2026

Allogene Therapeutics (NASDAQ:ALLO) Shares Up 11.9%What's Next? - marketbeat.com

Mar 31, 2026

Mar 31, 2026

Why Allogene Therapeutics (ALLO) says its lead cancer program is still on track in 2026 - MSN

Mar 31, 2026

Mar 30, 2026

If You Invested $1,000 in Allogene Therapeutics (ALLO) - Stock Titan

Mar 30, 2026

Mar 29, 2026

Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026 - Yahoo Finance

Mar 29, 2026

Mar 28, 2026

5 Penny Stocks with Potential to Rise 1000 Percent - Insider Monkey

Mar 28, 2026

Mar 28, 2026

Risk Check: Will Allogene Therapeutics Inc benefit from geopolitical trends2026 Biggest Moves & Real-Time Buy Zone Alerts - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

Allogene Therapeutics advances CAR T therapy to expand access for patients - Traders Union

Mar 27, 2026

Mar 27, 2026

ALLO Technical Analysis | Trend, Signals & Chart Patterns | ALLOGENE THERAPEUTICS INC (NASDAQ:ALLO) - chartmill.com

Mar 27, 2026

Mar 26, 2026

Worthington Steel Posts Downbeat Earnings, Joins MillerKnoll And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 26, 2026

Mar 26, 2026

Allogene Therapeutics (NASDAQ:ALLO) Upgraded at Truist Financial - MarketBeat

Mar 26, 2026

Mar 24, 2026

Allogene Therapeutics (NASDAQ:ALLO) Stock Price Down 9.2%Here's Why - MarketBeat

Mar 24, 2026

Mar 24, 2026

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 24, 2026

Mar 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 23, 2026

Mar 23, 2026

Allogene Therapeutics (NASDAQ:ALLO) Shares Up 11.4%Time to Buy? - MarketBeat

Mar 23, 2026

Mar 22, 2026

Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index - marketscreener.com

Mar 22, 2026

Mar 21, 2026

Allogene targets pivotal ALPHA3 data in April and extends cash runway into 2028 while prioritizing scalable CAR T programs - MSN

Mar 21, 2026

Mar 20, 2026

Piper Sandler Analysts Bullish on Allogene Therapeutics (ALLO) Ahead of Key ALPHA3 Data Readout - Insider Monkey

Mar 20, 2026

Mar 18, 2026

Allogene Therapeutics (NASDAQ:ALLO) SVP Sells $11,942.45 in Stock - MarketBeat

Mar 18, 2026

Mar 18, 2026

David Chang Sells 47,763 Shares of Allogene Therapeutics (NASDAQ:ALLO) Stock - MarketBeat

Mar 18, 2026

Mar 18, 2026

Allogene (NASDAQ: ALLO) SVP share sale funds tax withholding - Stock Titan

Mar 18, 2026

Mar 18, 2026

Allogene (ALLO) CEO executes 47,763-share tax sell-to-cover transaction - Stock Titan

Mar 18, 2026

Mar 18, 2026

Allogene Therapeutics targets new approach to autoimmune conditions with ALLO-329 - Traders Union

Mar 18, 2026

Mar 17, 2026

Allogene Therapeutics (NASDAQ:ALLO) Stock Price Down 5.1%Time to Sell? - MarketBeat

Mar 17, 2026

Mar 17, 2026

Take the Zacks approach to beat the markets: Starbucks, Amgen, Allogene in focus - MSN

Mar 17, 2026

Mar 16, 2026

Allogene Therapeutics (NASDAQ: ALLO) proposes sale of 4,835 shares - Stock Titan

Mar 16, 2026

Mar 16, 2026

Allogene Therapeutics (NASDAQ: ALLO) RSUs Vest, 47,763 Common Shares - Stock Titan

Mar 16, 2026

Mar 16, 2026

ALLO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 16, 2026

Mar 16, 2026

Citizens reiterates Allogene stock rating on pipeline progress By Investing.com - Investing.com South Africa

Mar 16, 2026

Mar 16, 2026

Citizens reiterates Allogene stock rating on pipeline progress - Investing.com

Mar 16, 2026